IceCure Medical (ICCM) Equity Average (2021 - 2024)

IceCure Medical (ICCM) has 4 years of Equity Average data on file, last reported at $9.5 million in Q4 2024.

• Quarterly Equity Average fell 49.28% year-over-year to $9.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $9.5 million (down 49.28% YoY) and the FY2025 annual result came in at $8.0 million, down 16.32% from the prior year.
• Equity Average eased to $9.5 million in Q4 2024 per ICCM's latest filing, from $18.8 million in the prior quarter.
• Across five years, Equity Average topped out at $26.2 million in Q4 2022 and bottomed at $9.5 million in Q4 2024.
• The 4-year median for Equity Average is $17.5 million (2021), against an average of $17.7 million.
• The widest annual swing landed in 2022, when Equity Average jumped 60.65%; it then slumped 49.28% in 2024.
• Tracing ICCM's Equity Average over 4 years: stood at $16.3 million in 2021, then surged by 60.65% to $26.2 million in 2022, then fell by 28.25% to $18.8 million in 2023, then sank by 49.28% to $9.5 million in 2024.
• Per Business Quant, the three latest ICCM Equity Average figures stand at $9.5 million (Q4 2024), $18.8 million (Q4 2023), and $26.2 million (Q4 2022).

Peer Comparison